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Persistent infection with human cytomegalovirus (HCMV)
infection is extremely common in many parts of the
world. Indeed, in the Pakistani population this is reported
to be more than 90%, when measured using HCMV
specific IgG antibody.1-4 HCMV-IgMsero-prevalence was
4.3%, but the rate for both IgM and IgG was also 4.1%,
indicating that reactivation of latent HCMV infection or
reinfection with a new strain is the major cause of IgM
seropositivity rather than primary infection.1 Mujtaba G
et al (2016) report 97.5% and 58.5% IgG seropositivity in
pregnant women and neonates respectively.2 Two
additional studies by Rizvi CB et al (2015), and Mahmood
R et al (2014) report a prevalence of 96.5% and 97.8%in
blood donors.3,4 Similar findings are reported from studies
done in Asian, African, and South American countries, in
contrast to the much lower HCMV prevalence in North
American and European countries.5-9 HCMV prevalence is
high in low-middle income countries, tending to be 20-
30% higher in non-white than in white populations.6,7
Primary HCMV infection in healthy individuals is usually
asymptomatic, and may present with a mild febrile illness,
mimicking infectious mononucleosis.10 HCMV Infection
persists for life in a latent form with periodic reactivation
or reinfection by a different strain. Common modes of
transmission include saliva, tears, milk, urine, stools, blood
and bodily fluids, and organ transplant.5,10 Congenital
HCMV infection (placental transmission) can result from
primary or secondary (reactivation or re-infection)
maternal infection occurring anytime during pregnancy.
Congenital HCMV infection can cause intra-uterine
growth retardation; brain maldevelopment syndromes;
congenital and progressive hearing loss;
thrombocytopenia; vision loss; motor disabilities such as
cerebral palsy; liver and spleen disorders including
hepato-splenomegaly; and other illnesses.5,6 Notably,
infants acquiring primary maternal HCMV infection
display much severe form of HCMV-associated sequelae.
The epidemiology of vertical transmission of HCMV
infection and related congenital anomalies in Pakistani
population is not well studied. hHCMV prevalence in
South Asian women was higher HCMV prevalence who
were born in South Asia compared to those born in UK.6
In the west HCMV infects 2 to 4% of pregnant women for
the first time as a primary infection during pregnancy, and
it is transmitted to the foetus, resulting in a congenital
infection in 40% of these pregnant women.5,8 However, in
Pakistan the number of pregnant women infected during
pregnancy is not known, but is most probably much
higher.2 Congenital CMV in low- and middle-income
countries and is mostly due to secondary maternal
infections; whereas, in western settings with moderate
levels of seroprevalence (70% in USA) 25% of congenital
CMV are due to primary and 75% due to secondary
maternal infections, in countries where seroprevalence is
relatively low (50% European countries), primary and
secondary infections contribute equally for occurrence of
congenital CMV infection.9
Individuals with HCMV can be co-infected with other
widely distributed herpes viruses like Epstein-Barr, and
varicella-zoster.10 These viral infections have a tendency
to persist for a lifetime as latent infections. In order to
keep the virus in check the immune system mounts a
constant response, impacting its effectiveness against
other infections, cancer, auto-immune diseases, and
response to vaccinations.  Such a phenomenon could be
one of the reason as to why in Pakistan some of these
conditions (cancer, autoimmune, other) present earlier
than in the western populations. Moreover, such immune
suppression in elderly population has been reported to
reduce life expectancy.11
HCMV infected blood transfusion can cause severe illness
or death among elderly or persons with low immunity.3 In
fact, allogenic stem cell transplant center in Islamabad
reported 88% of its patients over a period of five years
were HCMV positive and similar number of donors were
also CMV positive.12 Mortality in post-transplant patients
was mainly due to CMV enterocolitis/pneumonia, and lack
of anti-viral medicines was also one of the major
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problem.12 Antiviral drug therapy for HCMV prevention
and treatment for transplants and selective cases of
hearing loss by congenital HCMV carries a high cost of
treatment that could vary from US$25,000 to
US$30,000.8,13,14
HCMV is a seminal neglected public health area of
significant relevance to women and children. It infects
large swaths of population in the developing world,
however, most people across the globe have never heard
of it.5-9 Health care providers do not counsel mothers
about CMV transmission.15 There is significant lack of
knowledge and awareness among health care providers
and the general population in Pakistan regarding HCMV,
modes of transmission and potential consequences of
becoming infected. One group who should be made
aware of HCMV are females in the reproductive age group
and breast feeding mothers. This group is prone as well as
a reservoir for HCMV infection, and a source of
transmission to the foetuses and neonates.5,6,9,15,16 Sero-
negative women may acquire infection during pregnancy
with significant sequelae for the foetus. There is an urgent
need for health care professionals in particular all those
engaged in prenatal, antenatal and postpartum care of
women in rural, peri-urban and urban areas to be
educated about HCMV and its mode of transmission.9,15,16
This requires a vigorous education campaign by local,
provincial and national public health organizations. 
It is the authors contention that much can be done now to
reduce HCMV infection in women of child bearing age
and pregnant women thereby reducing HCMV
transmission to the foetus and newborn.  How can this be
done?  In the west an approach aptly called the, "CMV
Vaccine" has been proposed by experts.  There have been
successful attempts to develop a vaccine for HCMV that
still needs validation studies.16,17 The administration of
the "CMV Vaccine" contextualized for the Pakistani
population will reduce HCMV transmission and infection
of the foetus and new born.8,9,15,16 Further to vaccine
development, a randomized trial of immunoglobulin and
placebo among pregnant women did not reduce vertical
transmission of HCMV infection.18
There are implications for areas of prevention to be
adopted by parents, health care givers, population in
general for diagnosis and management of HCMV
infection. Estimates of disabilities due to HCMV infection
are lacking from Pakistani and similar type of populations.
However, western setting population share advancement
in clinical virology in all areas of diagnostics and
management of HCMV especially since Acquired Immune
Deficiency Syndrome (AIDS) patients and transplant
recipients remain at high risk of HCMV infection.19 Low
levels of viral replication in latently infected individuals,
maintain viral genomes in mononuclear cells and bone
marrow, allow subsequent replication in response to
inflammation, and low immune states like pregnancy,
chemotherapy, corticosteroid therapy.  Hence guidelines
are needed for infections in such vulnerable hosts in a
developing country setting.  
In Pakistani population, major task with health care
providers is to recommend hygienic precautions such as
appropriate hand washing and wearing gloves during
diaper change of children especially when performed by
seronegative individuals. Raising awareness by
instructing mothers and family members to avoid
intimate contact with infants and young children may also
aid in reducing horizontal transmission of HCMV
infection. Other than contact with children, sexual contact
may also transmit HCMV to seronegative women. Blood
transfusion is common due to endemic thalassemia trait
and alternative strategies need to be investigated to
reduce the disabilities, morbidity and mortality in
debilitated patients who need blood transfusion.  As such,
6.6% of the adult population remain at risk of HCMV
infection in Pakistan1 and it is likely that limited use of
sharing edibles, and utensils and other hygienic
behaviour were responsible for lack of transmission of
HCMV infection. However, this needs to be tested in
future research to identify the hygienic behaviours
determining reduced risk of HCMV transmission in a
country like Pakistan with a very high HCMV prevalence.
Low socioeconomic status as a determinant of HCMV
infection can only be modified, by stringent
implementation of public health strategies including
HCMV prevention and vaccination programmes on a
national level to remove the increasing transmission in
existing cohorts of uninfected population.  
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